Tofacitinib as a Steroid-Sparing Therapy in Pulmonary Sarcoidosis, an Open-Label Prospective Proof-of-Concept Study

Steroid-resistant sarcoidosis treated with baricitinib

(2020) Morton Scheinberg et al.   ANNALS OF THE RHEUMATIC DISEASES

Tofacitinib for cutaneous and pulmonary sarcoidosis: a case series

(2020) Karolina L. Kerkemeyer et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The St. George’s Respiratory Questionnaire in Pulmonary Sarcoidosis

(2020) K. H. Lo et al.   LUNG

Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare

(2019) William Damsky et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Pulmonary sarcoidosis

(2018) Paolo Spagnolo et al.   Lancet Respiratory Medicine

Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis

(2018) William Damsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Identification of Jak-STAT signaling involvement in sarcoidosis severity via a novel microRNA-regulated peripheral blood mononuclear cell gene signature

(2017) Tong Zhou et al.   Scientific Reports

The effect of corticosteroids on quality of life in a sarcoidosis clinic: The results of a propensity analysis

(2015) Marc A. Judson et al.   RESPIRATORY MEDICINE

Sarcoidosis Blood Transcriptome Reflects Lung Inflammation and Overlaps with Tuberculosis

(2011) Laura L. Koth et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Hypothesis: Sarcoidosis is a STAT1-mediated disease

(2009) James T. Rosenbaum et al.   CLINICAL IMMUNOLOGY